Discontinued — last reported Q3 '24
Business Segments · Restructuring Charges
Consumer Tissue Products — Restructuring Charges
Kimberly-Clark Consumer Tissue Products — Restructuring Charges increased by 54.2% to $37.00M in Q3 2024 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ1 2018
Last reportedQ3 2024
Rolls up toRestructuring Charges
How to read this metric
High charges indicate significant operational restructuring, which may temporarily depress earnings but is intended to improve future margins.
Detailed definition
This metric quantifies the costs associated with organizational changes, facility closures, or efficiency programs speci...
Peer comparison
Frequent or high restructuring charges relative to peers may indicate a need for ongoing operational modernization.
Metric ID:
kmb_segment_consumer_tissue_products_restructuring_chargesHistorical Data
6 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|
| Value | $26.00M | $42.00M | $34.00M | $4.00M | $24.00M | $37.00M |
| QoQ Change | — | +61.5% | -19.0% | -88.2% | +500.0% | +54.2% |
Range$4.00M – $42.00M
CAGR+32.6%
Current Streak2 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Kimberly-Clark's consumer tissue products — restructuring charges?
- Kimberly-Clark (KMB) reported consumer tissue products — restructuring charges of $37.00M in Q3 2024.
- What does consumer tissue products — restructuring charges mean?
- The amount of one-time costs incurred to reorganize or improve the efficiency of the consumer tissue segment.